获利能力 Profitability (单位:美元)
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 净资产收益率(ROE) | 13.63% | 15.95% | 14.08% | 17.78% | 16.30% | 15.85% | 14.83% | 13.29% |
| 总资产收益率(ROA) | 5.24% | 6.21% | 5.28% | 6.32% | 5.74% | 5.50% | 5.12% | 4.66% |
| 毛利率 | 100.00% | 98.09% | 92.65% | 92.14% | 91.68% | 89.91% | 88.84% | 89.36% |
| 净利率 | 4.07% | 4.61% | 3.75% | 4.44% | 3.76% | 3.50% | 3.37% | 2.84% |
| 每股收益(EPS) | 14.53 | 18.81 | 18.23 | 25.26 | 24.56 | 25.38 | 25.81 | 25.28 |
财务结构 Financial Structure
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | 5.50% | 6.37% | 6.63% | 5.01% | 7.19% | 5.99% | 7.09% | 7.81% |
| 负债占总资产比率 | 60.12% | 59.04% | 61.67% | 62.93% | 64.64% | 63.82% | 64.56% | 63.76% |
经营能力 Operating Capability
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | 20.63 | 20.78 | 21.89 | - | - | - | - | - |
| 平均收现日数 | 18 天 | 18 天 | 17 天 | - | - | - | - | - |
| 固定资产周转率(次) | 0.0297 | 0.0301 | 0.0301 | 0.0283 | 0.0276 | 0.0254 | 0.0263 | 0.0235 |
| 总资产周转率 | 128.69% | 134.55% | 133.41% | 142.25% | 152.40% | 157.30% | 151.26% | 163.90% |
现金流量 Cash Flow (单位:亿美元)
| 指标 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | 39.34 | 49.37 | 57.41 | 48.80 | 73.87 | 65.26 | 82.88 | 94.91 |
| 净利润 | 37.50 | 48.07 | 45.72 | 61.58 | 58.94 | 59.87 | 59.80 | 56.62 |
| 经营活动现金流量 | 38.27 | 60.61 | 106.88 | 83.64 | 83.99 | 80.61 | 58.08 | 42.90 |
| 投资活动现金流量 | -12.59 | -27.92 | -73.24 | -96.38 | -45.60 | -55.72 | -51.67 | -13.44 |
| 筹资活动现金流量 | -22.41 | -22.66 | -25.67 | 4.23 | -13.18 | -33.49 | 11.93 | -17.38 |
| 净现金流量 | 3.25 | 10.03 | 8.04 | -8.61 | 25.07 | -8.61 | 18.28 | 12.03 |
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
25.81%
吉利德科学
GILD
28
24.45%
再生元制药
REGN
29
23.09%
德康医疗
DXCM
30
23.02%
瑞思迈
RMD
31
15.61%
Elevance Health Inc
ELV